ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $11,978,000 | +79.8% | 258,533 | -5.4% | 0.01% | +85.7% |
| Q1 2019 | $6,660,000 | +71.4% | 273,165 | +0.2% | 0.01% | +40.0% |
| Q4 2018 | $3,886,000 | -13.1% | 272,698 | -7.3% | 0.01% | +25.0% |
| Q3 2018 | $4,472,000 | -7.1% | 294,229 | +2.6% | 0.00% | -20.0% |
| Q2 2018 | $4,812,000 | +5.7% | 286,756 | +2.8% | 0.01% | 0.0% |
| Q1 2018 | $4,552,000 | +25.6% | 278,947 | -1.5% | 0.01% | +25.0% |
| Q4 2017 | $3,624,000 | +4.2% | 283,102 | +0.1% | 0.00% | 0.0% |
| Q3 2017 | $3,478,000 | +30.4% | 282,771 | -11.3% | 0.00% | 0.0% |
| Q2 2017 | $2,667,000 | -6.1% | 318,666 | +0.3% | 0.00% | 0.0% |
| Q1 2017 | $2,840,000 | +146.5% | 317,690 | +142.5% | 0.00% | +100.0% |
| Q4 2016 | $1,152,000 | +380.0% | 131,012 | +130.3% | 0.00% | – |
| Q4 2015 | $240,000 | -50.7% | 56,883 | -46.7% | 0.00% | -100.0% |
| Q3 2015 | $487,000 | -48.1% | 106,700 | -18.1% | 0.00% | -50.0% |
| Q2 2015 | $939,000 | +122.5% | 130,293 | +127.7% | 0.00% | +100.0% |
| Q1 2015 | $422,000 | +18.5% | 57,218 | -24.4% | 0.00% | 0.0% |
| Q1 2014 | $356,000 | -53.8% | 75,718 | -50.8% | 0.00% | -50.0% |
| Q4 2013 | $771,000 | -32.5% | 153,918 | -16.3% | 0.00% | -50.0% |
| Q3 2013 | $1,143,000 | -53.7% | 183,818 | -66.2% | 0.00% | -55.6% |
| Q2 2013 | $2,471,000 | +37.3% | 544,218 | +12.5% | 0.01% | +12.5% |
| Q4 2012 | $1,800,000 | – | 483,918 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|